Eli Lilly and Company (ETR:LLY)
Germany · Delayed Price · Currency is EUR 645.20
-4.40 (-0.68%)
Sep 19, 2025, 5:35 PM CET
Eli Lilly and Company Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
€964,878
Profits / Employee
€250,013
Market Cap
574.77B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fresenius Medical Care AG | 111,513 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,730 |
Eli Lilly and Company News
- 1 day ago - Inside the Race to Launch GLP-1 Weight-Loss Pills - WSJ
- 1 day ago - 19.9% of VHT Holdings Seeing Recent Insider Buys - Nasdaq
- 1 day ago - This Unstoppable Healthcare Stock Just Made a Move in AI: Time to Buy? - The Motley Fool
- 2 days ago - Eli Lilly (LLY) Positioned for Market Share Gains Amid Competitor's Downsizing - GuruFocus
- 2 days ago - Here's Why Novo Nordisk and Eli Lilly Could Still Be Absurdly Underrated Stocks to Buy Today - The Motley Fool
- 2 days ago - Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs - Benzinga
- 2 days ago - LLY's Orforglipron Tops NVO's Oral Pill in Diabetes Study: What's Next? - Nasdaq
- 2 days ago - No more need for needles: A new generation of GLP-1 weight-loss drugs in pill form is coming closer - WSJ